General Electric has agreed to give Alstom three additional weeks to consider GE's $17 billion offer for the French engineering company's energy-related operations.
Harman International Industries Inc. said Wednesday that it is buying audio and visual equipment maker AMX LLC for $365 million.
The firms, both based in the Portland area, said joining Oregon Iron Works' fabrication abilities with Vigor's shipbuilding and marine-launch capabilities allows them to complete large-scale projects that neither company could do alone.
Unilever PLC says it has agreed to sell ownership of its Ragu and Bertolli brand sauces in North America to Japan's Mizkan Group for $2.15 billion.
Another AstraZeneca shareholder has criticized the pharmaceutical company's handling of Pfizer's $119 billion takeover bid, saying it was "arguably wrong" to reject it quickly.
Pressed to provide more details about its plans for its overseas cash, Google revealed that $20 billion to $30 billion is earmarked for the acquisition of foreign companies and technology rights held outside the U.S.
AstraZeneca shareholder Schroders has urged the pharmaceutical firm to reconsider its rejection of a takeover offer from U.S. drugmaker Pfizer.
Aeroflex, based in Plainview, New York, makes products and test equipment used by the aerospace, medical and wireless industries. Cobham makes everything from aircraft fuel tanks to antennas.
Pfizer Inc., which is the world's second-biggest drug maker by revenue, has been courting No. 8 AstraZeneca PLC since January, arguing that their businesses are complementary and would be stronger together.
Abbott Laboratories says it will spend about $2.9 billion to broaden its reach in Latin America with the acquisition of fellow drugmaker CFR Pharmaceuticals.
Merck & Co. will receive at least $600 million in a deal with Japanese drug maker Santen Pharmaceutical Co. Ltd. for the purchase of Merck eye care products in several markets.
German automaker Volkswagen AG has enough shares to take complete ownership of Swedish truck-maker Scania and move ahead with integrating its commercial vehicle business.
Lawmakers pressed the chief executive of Pfizer to guarantee jobs should the American company succeed in taking over London-based AstraZeneca, prodding him on whether he could be trusted to honor promises made as part of the bid.
Two former Qualcomm Inc. managers were criminally charged with insider trading for allegedly buying shares of a semiconductor maker before Qualcomm announced an agreement to buy the company.
Botox maker Allergan is rejecting a takeover bid from Valeant Pharmaceuticals, saying that the unsolicited $46 billion offer undervalues the company and carries significant risk.
Chrysler Group lost $690 million in the first quarter due to charges related to its merger with Italian automaker Fiat SpA.
Hillshire Brands is buying Pinnacle Foods, whose brands include Duncan Hines and Aunt Jemima, in a cash-and-stock deal valued at approximately $4.23 billion.
Apple is orchestrating a $3.2 billion acquisition of Beats Electronics, the headphone maker and music streaming distributor founded by hip-hop star Dr. Dre and record producer Jimmy Iovine, according to a published report.
The deal is part of a $3.5 billion restructuring program underway at Mondelez that is projected to create $1.5 billion in savings by 2018.
The pretzel and chip maker is selling its private brands and two manufacturing plants to Shearer's Foods LLC for $430 million as it hones its focus on its well-known brands.
French President Francois Hollande says that an offer by General Electric Co. for troubled French engineering company Alstom is not good enough and wants the U.S. company to come up with a better deal.
Bayer has agreed to buy Merck & Co.'s non-prescription medicine and consumer care business for $14.2 billion, gaining products such as Claritin allergy pills, Coppertone sun lotion and Dr. Scholl's footcare products.
Executives at drug maker Pfizer Inc. say they're continuing to review options after British rival AstraZeneca PLC again rejected their proposal to buy the company, adding that Pfizer would prefer a friendly deal.
That is one of the strategic options the company said over the weekend that it was considering, as well as merging with another company or spinning off one of its businesses.
The board of pharmaceutical company AstraZeneca on Friday flatly rejected drug maker Pfizer's sweetened takeover offer just hours after it was levelled, describing it as inadequate.